Study shows cannabis drinks halve alcohol use

A University at Buffalo study indicates that cannabis-infused beverages may help reduce alcohol consumption among users. Survey participants who switched to these drinks reported cutting their weekly alcohol intake nearly in half. Nearly two-thirds of respondents said they reduced or stopped drinking alcohol after starting cannabis beverages.

Researchers at the University at Buffalo conducted a survey of 438 anonymous adults who had used cannabis in the past year, with about 56% also consuming alcohol. Approximately one-third of participants reported using cannabis beverages, typically one per occasion. The study, published in the Journal of Psychoactive Drugs, marks the first examination of cannabis beverages as a tool for alcohol harm reduction.

Harm reduction aims to minimize the negative effects of substance use without requiring complete abstinence. Jessica Kruger, PhD, a clinical associate professor at UB's School of Public Health and Health Professions and the study's first author, stated, "In the first study of its kind, we introduce the concept of having cannabis as harm reduction for alcohol. Cannabis has been proposed as harm reduction for other drugs such as opioids but not talked about as often for legal substances such as alcohol."

Participants who used cannabis beverages were more likely to substitute them for alcohol, with 58.6% reporting this compared to 47.2% for other cannabis products. Most beverages contained 10 mg of cannabidiol (CBD) or less, according to 89.5% of users. After starting cannabis drinks, average weekly alcohol consumption dropped from 7.02 drinks to 3.35, and binge drinking episodes decreased.

Of the respondents, 62.6% reduced alcohol intake, including 61.5% who cut back and 1.1% who stopped entirely, while 3.3% reported increased drinking. Daniel Kruger, PhD, a co-author, noted, "Several previous studies, including ours, have demonstrated that people have reduced their alcohol consumption by switching to cannabis. It's remarkable that people who use cannabis beverages report an even greater reduction in alcohol use than those who use other types of cannabis products... We believe this may be because of the similarity in administration method and context of use -- people at parties or bars will likely have a drink in their hand, in this case a cannabis beverage rather than an alcoholic one."

Cannabis beverage sales are projected to exceed $4 billion globally by 2028, per Euromonitor. In New York State, legal sales began in January 2023, with 82% of surveyed users buying from licensed dispensaries. The researchers, including Nicholas Felicione, PhD, plan further studies on long-term effects. UB thanked partners Premier Earth and Star Buds for survey assistance.

Relaterede artikler

Scientists in a lab watch rats reject alcohol bottles after tirzepatide treatment from Mounjaro, highlighting new hope for alcoholism therapy.
Billede genereret af AI

Ny undersøgelse giver håb for vægttabsmedicin mod alkoholisme

Rapporteret af AI Billede genereret af AI

En ny undersøgelse fra University of Gothenburg viser, at tirzepatid, det aktive stof i diabetes- og vægttabsmedicin Mounjaro, reducerer alkoholindtag og tilbagefaldslignende adfærd hos rotter og mus. Dette bygger på tidligere forskning om semaglutid i Ozempic og Wegovy, som dæmper alkoholforbrug hos mennesker. Forskere håber på lignende effekter hos patienter med alkoholafhængighed.

Two breweries in Greater Cincinnati have filed a lawsuit challenging Ohio's upcoming ban on intoxicating hemp products. The suit targets state officials and argues that the restrictions could harm businesses significantly. The ban stems from a law signed by Governor Mike DeWine last year.

Rapporteret af AI

A major review published in The Lancet Psychiatry concludes that medicinal cannabis does not effectively treat anxiety, depression or post-traumatic stress disorder. The analysis of 54 randomized controlled trials over 45 years found limited evidence for other conditions like insomnia and autism. Researchers warn of potential harms including psychosis risk and delayed effective treatments.

The National Health Surveillance Agency (Anvisa) approved, on January 28, 2026, resolutions allowing cannabis cultivation for health treatments and research, along with new administration routes and plant imports. This step marks progress in the national production chain, easing access to plant-derived medicines. The changes broaden options for patients with severe illnesses while upholding strict restrictions.

Rapporteret af AI

Liquor traders in South Africa have expressed concerns that a proposed increase in alcohol taxes could harm their businesses and fuel the illicit alcohol trade. The National Treasury plans to raise excise duties in the 2025/26 financial year to address alcohol abuse. Industry leaders argue that higher prices alone won't solve consumption issues and may drive consumers to illegal alternatives.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis